BR — Broadridge Financial Solutions, Inc.

Analysts remain constructive (15 Buy/9 Hold/0 Sell; average PT around $201) and Q4 FY2026 beat with 8% recurring revenue growth, a 12% dividend raise, and tokenization traction. But price action is unconvincing: as of 2026-09-13, shares were -2.97% over 1 week, -5.93% over 6 months, RSI 43.7, below both the 20-day and 200-day SMAs, so the market is not yet rewarding the fundamental beat.

Revenue growth is steady, not accelerating: quarterly YoY was +7.8% in Dec-25, +7.8% in Mar-26, and +7.6% in Jun-26, after +11.7% in Sep-25; FY2026 recurring revenue grew 8% constant currency. Margins are expanding overall: Jun-26 operating margin 24.6% vs 24.1% a year earlier; Sep-25 11.9% vs 9.5%; Dec-25 12.2% vs 13.3% (slight compression); Mar-26 18.4% vs 19.0% (slight compression). EPS is trending up: Q4 diluted EPS $3.44 vs $3.16, full-year adjusted EPS $9.60 +12%. The trend is stable-to-improving, with seasonality intact and no structural deceleration.

Cheap vs its own history and fair-to-attractive absolute: as of 2026-09-13, TTM P/E 17.3x vs 5-year average 28.6x; forward P/E about 15.9x on next-FY EPS $10.555; PEG 0.49; dividend yield 2.24%; EV/EBITDA 11.8x. The market is pricing mid-single-digit growth despite 8-12% guided adjusted EPS growth and 110% free cash flow conversion. Not deep-value cheap, but a clear discount to its historical multiple.

The stock is not pricing in the FY2027 guide: at $167.74 and $10.555 next-FY EPS, it trades at 15.9x, below its own 5-year average and below many quality-fintech peers. If Broadridge hits 6-8% recurring revenue and 8-12% adjusted EPS growth, multiple expansion to 19-20x is plausible; if closed sales or tokenization adoption slip, the cheap multiple can persist. Watch quarterly recurring revenue and closed sales ($305M FY2026) rather than GAAP EPS noise.

As of 2026-09-13, RSI 43.7 is neutral, not oversold. Price is 4.95% below the 20-day SMA, 2.61% above the 50-day SMA, and 4.67% below the 200-day SMA. The 3-month return +15.79% shows a bounce, but the 6-month return -5.93% and 1-week return -2.97% show fading momentum. Range-bound/weak; wait for a reclaim of the 200-day SMA or a pullback toward the 50-day with stronger volume before treating it as a confirmed uptrend.

• Interest-rate path and capital-markets activity: transaction-based GTO revenue is tied to trade volumes and asset/position growth; higher-for-longer rates can pressure institutional activity and high-multiple fintech valuations.
• Regulatory complexity: proxy rules, ESG reporting, and digital communication compliance create non-discretionary demand for Broadridge's ICS/GTO solutions.
• Tokenization and DLT adoption: institutional repo and tokenized securities are secular tailwinds; Broadridge's DLR processed a record $8T monthly volume and the DLX launch positions it early.
• Financial-sector IT budgets: bank and wealth-manager spending on back-office efficiency and compliance is a key swing factor.
• Currency and global expansion: G7 securities expansion and constant-currency reporting mean FX and cross-border adoption affect reported growth.

• FY2027 execution: management targets 6-8% constant-currency recurring revenue growth and 8-12% adjusted EPS growth; early-quarter closed sales and recurring revenue will confirm or break the thesis.
• Commercial adoption of DLX and tokenized repo; scaling G7 tokenized volumes from record DLR levels into revenue.
• Continued capital returns: 12% dividend raise to $4.36 (20th consecutive annual increase) and record buybacks supported by 110% FCF conversion.
• Potential multiple re-rating if rates ease and investors rotate back to quality recurring-revenue fintech.

• Multiple/rate risk: at 17.3x TTM P/E the stock is cheaper than history, but if rates stay high, fintech de-rating can continue despite solid fundamentals.
• Transaction-volume dependence: a market downturn, weak trading volumes, or lower investor account/position growth would pressure GTO/ICS revenue.
• Execution risk on tokenization/AI investments: DLX and DLT revenue may take years to materialize; spending could weigh on margins before payback.
• Balance-sheet leverage: long-term debt rose to $3.25B at Jun-26 from $2.75B a year earlier; D/E 1.24 and current ratio 1.24 leave less cushion if rates rise or FCF slows.
• Regulatory change in proxy distribution or communications could alter pricing/economics.

Broadridge is a high-quality, wide-moat financial infrastructure compounder with recurring revenue, expanding margins, strong FCF, and a 20-year dividend-growth streak. At 15.9x forward EPS it is cheaper than its own history and the analyst consensus sees about 20% upside, but the deterministic score sits at Fair Fundamentals and the technicals are still unconfirmed below the 200-day SMA. I would call it a watchlist/accumulate-on-weakness name, not an urgent buy.

Applied a 19.5x forward P/E to next-FY consensus EPS of $10.555. The multiple is below BR's 5-year average P/E of 28.6x but above the current 15.9x forward P/E, reflecting 8-12% adjusted EPS growth, recurring revenue, wide-moat infrastructure, and strong FCF conversion; 19.5 x 10.555 = $205.82.